Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Metal-on-Metal Hip Problems Known for Years by DePuy Orthopaedics: Report April 12, 2017 Irvin Jackson Add Your Comments A recent investigative report in the United Kingdom suggests that DePuy Orthopaedics knew or should have known about serious dangers associated with their metal-on-metal hip replacement systems as early as 1995, raising questions about the decision to continue to market and promote their DePuy Pinnacle and DePuy ASR implants, which have been linked to thousands of reports involving catastrophic failures and complications.. The Daily Telegraph has released a series of internal documents that appear to reveal concerns that date back decades, with senior engineers even then warning that the metal-on-metal hips may shed metal debris. Those same complaints have been made by thousands of individuals in the United States have have filed DePuy Pinnacle hip lawsuits, DePuy ASR hip lawsuits, and cases against other manufacturers of metal-on-metal hip designs in recent years. Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Hip Replacement Lawsuits If you or a loved one experienced complications or needed revision surgery due to a defective hip implant, you may be entitled to financial compensation. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Metal-on-metal hip replacements have been sold by a number of different manufacturers in recent years, featuring a metal femoral head that rotates within a metal acetabular cup. Most of the devices were introduced through the controversial fast-track 510(k) approval process, which only required that the device be a “substantial equivalent” to an already existing device approved by the FDA. However, the snowball effect of the substantial equivalence test has allowed many devices now considered unreasonably dangerous and defective to be implanted in thousands of Americans. Unlike other artificial hip designs, which typically feature metal-on-ceramic or metal-on-plastic, the metal-on-metal hips have been found to release microscopic metallic debris as the parts rub against each other. This has been linked to reports of loosening and failure, often within a few years after the artificial hip is implanted. In one letter disclosed by the Daily Telegraph, a doctor indicated that he warned DePuy about metal-on-metal (MOM) hip problems for more than a decade. “I do not feel DePuy is doing enough to understand the extent of Pinnacle MOM hip disease,” Dr. John F. Irving wrote in one of the recently revealed documents. “I believe it borders on unethical to continue to market the product until the issues are elucidated. These products are harming patients.” Minutes from a 1995 meeting show that there were concerns even back then. The minutes mention high volume particle generation, metal ion release and poor wear results as current issues even back then. Ignoring those early warnings appear to now be costing DePuy, a subsidiary of Johnson & Johnson, in the court room. A federal jury awarded over $1 billion in damages during a DePuy Pinnacle hip bellwether trial in early December, including punitive damages designed to punish the manufacturer for their actions involving the design and sale of the controversial implant, which is the subject of nearly 10,000 similar product liability lawsuits pending nationwide. Each of the lawsuits filed over DePuy Pinnacle hip problems are pending before U.S. District Judge Ed Kinkeade, raising nearly identical allegations that the metal-on-metal implant is prone to loosen and fail as metallic debris is released into the body, resulting in severe pain and the need for revision surgery to remove the artificial hip. In addition to the recent $1 billion verdict, which involved a group of plaintiffs from California, an earlier bellwether trial involving a group of five plaintiffs from Texas resulted in a $500 million verdict in March 2016, including $140 million in combined compensatory damages and another $360 million in punitive damages. However, that verdict was reduced to $151 million under Texas state laws, which has more stringent damage caps. Another DePuy Pinnacle bellwether trial is expected to go before a juryl in September 2017, unless the manufacturer takes steps to settle the hip lawsuits before then. Johnson & Johnson previously agreed to pay more than $2.4 billion to settle DePuy ASR metal hip lawsuits, resolving about 8,000 cases brought on behalf of individuals who received this newer metal-on-metal hip design, which was recalled from the market in 2010. However, the manufacturer has refused to settle DePuy Pinnacle cases. While Johnson & Johnson has maintained that it intends to defend the DePuy Pinnacle cases at trial and through appeals, the manufacturer may face substantial liability if future juries respond in the same way to the evidence and testimony presented during the first two bellwether trials. Tags: DePuy, DePuy ASR, DePuy Pinnacle, Johnson & Johnson, Metal Blood Poisoning, Metal Hip Replacement, Metal-on-Metal Hip, Metallosis More DePuy ASR Hip Lawsuit Stories Biomet Hip Lawsuit Filed Over Defective M2A Metal-on-Metal Implant December 26, 2024 Zimmer Biomet Lawsuit Filed Over RibFix Blu Implant Fracture September 25, 2024 Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024 2 Comments derek May 2, 2017 Greetings from an Englishman in Bulgaria, a double THR DP XL victim. I attempted to find the Daily Telegraph UK article. Despite trawling their archives I was unable to find it. Please could you E Mail the date of publication? My original THR’s were implanted in England in 07 & 08 and caused problems shortly afterwards. As I could not afford to pay for revision it took several years to convince BroadSpire that I needed revision despite pain, disability and high ion levels. Eventually I got the approval and had both hips revised in Turkey in 2015 & 16. De Puy paid the hospital around 26,000 Eu per hip as well as covering the flight and hotel expenses for my wife and I. I know that US lawyers can only litigate for US based ops but I am struggling to find legal representation and time is ticking away. Incidentally the doctors in Turkey discovered that I have developed nerve and thyroid problems and told me that they may have developed due to heavy metal toxicity! Barry April 16, 2017 I had a DePuy Pinnacle hip put in November 2005 and was revised in July 2010. My hip joint was stained “black: from the metalosis, and 18 months after the revision, both my chromium and cobalt levels were 4 times the acceptable level. My body has pseudo through it, my hip joint has loosened and I need a pace maker for the damage the cobalt has done to my heart. Are there any Doctors or hospitals looking to study this? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns September 18, 2024
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)